sulfasalazine has been researched along with Adult-Onset Still Disease in 6 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belghali, S | 1 |
| El Amri, N | 1 |
| Baccouche, K | 1 |
| Laataoui, S | 1 |
| Bouzaoueche, M | 1 |
| Zeglaoui, H | 1 |
| Bouajina, E | 1 |
| Pérez-De Pedro, I | 1 |
| Miranda-Candón, I | 1 |
| Camps-García, MT | 1 |
| Gómez-Huelgas, R | 1 |
| Nordström, D | 1 |
| Knight, A | 1 |
| Luukkainen, R | 1 |
| van Vollenhoven, R | 1 |
| Rantalaiho, V | 1 |
| Kajalainen, A | 1 |
| Brun, JG | 1 |
| Proven, A | 1 |
| Ljung, L | 1 |
| Kautiainen, H | 1 |
| Pettersson, T | 1 |
| Singh, S | 1 |
| Samant, R | 1 |
| Joshi, VR | 1 |
| Haar, D | 1 |
| Svendsen, P | 1 |
| Helin, P | 1 |
| Crowley, J | 1 |
| Situnayake, RD | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open, Randomized Study Treating Refractory Adult-onset Still's Disease With Interleukin-1 Receptor Antagonist Anakinra (Kineret), Compared to an Established, Single Anti-rheumatic Drug Treatment[NCT01033656] | Phase 2 | 23 participants (Actual) | Interventional | 2005-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for sulfasalazine and Adult-Onset Still Disease
| Article | Year |
|---|---|
Beneficial effect of interleukin 1 inhibition with anakinra in adult-onset Still's disease. An open, randomized, multicenter study.
Topics: Adult; Antirheumatic Agents; Azathioprine; Female; Humans; Interleukin 1 Receptor Antagonist Protein | 2012 |
5 other studies available for sulfasalazine and Adult-Onset Still Disease
| Article | Year |
|---|---|
Atypical form of Adult-onset Still's Disease with Distal Interphalangeal Joints Involvement.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Arthritis; Finger Joint; Humans; Male; Methotrexate; | 2018 |
[Hemophagocytic syndrome in adult Still disease after initiation of sulfasalazine].
Topics: Adult; Antirheumatic Agents; Humans; Lymphohistiocytosis, Hemophagocytic; Male; Still's Disease, Adu | 2010 |
Adult onset Still's disease: a study of 14 cases.
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Contraindications; Cyclosporine; Diagnos | 2008 |
[Two cases of Still disease in adults].
Topics: Adult; Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Humans; Male; Sti | 1998 |
Sulphasalazine induced hepatitis in adult Still's disease.
Topics: Adult; Chemical and Drug Induced Liver Injury; Female; Humans; Still's Disease, Adult-Onset; Sulfasa | 1992 |